CG Bio is intensifying its efforts to educate medical professionals on complex cerebrovascular surgeries. The company’s strategy involves enhancing practical application in clinical settings through cadaver simulations that closely mimic real surgical environments for vascular bypass techniques, while also incorporating products used in post-operative skull defect reconstruction.
CGBIO recently hosted the 2026 Second RISE Cadaver Workshop at the Catholic University of Korea’s International Surgical Training Center, as announced on Thursday.
The event was designed to enhance neurosurgeons’ proficiency in extracranial-intracranial vascular bypass (EC-IC bypass) techniques and provide hands-on experience with neurosurgical reconstruction products in simulated surgical scenarios.
EC-IC bypass is a highly complex procedure that involves connecting extracranial and intracranial blood vessels to ensure adequate cerebral blood flow. Given the intricate nature of microvessel connections, a thorough understanding of anatomy and extensive practice are crucial.
This year’s workshop, themed Advanced Vascular Bypass Cadaver Workshop, featured a comprehensive program including theoretical lectures, hands-on cadaver practice, and product application training.
Participants learned anatomical approaches and surgical processes for major vascular bypasses, such as STA-MCA and OA-PICA bypasses. They then practiced the entire surgical procedure step-by-step on actual cadavers, including donor vessel dissection, recipient vessel exposure, vascular anastomosis, and leak testing.
CGBIO notably integrated vascular bypass practice with training on neurosurgical reconstruction products. Attendees gained firsthand experience in applying products like the EASYMADE NS Burr Hole, EASYMADE NS Gap Filler, and Novogride during the surgical completion phase.
The EASYMADE NS Burr Hole and Gap Filler are medical devices designed for reconstructing skull defects post-neurosurgery, while Novogride is a human tissue product processed into a fibrous sheet from donated dermal tissue.
The workshop was conducted in conjunction with the Daewoong Bio Symposium. CGBIO leveraged the group’s academic resources and educational infrastructure to deliver a comprehensive training program linking theory, advanced techniques, and product applications.
Looking ahead, CGBIO plans to expand the RISE Cadaver Workshop into a specialized training platform for medical professionals in cerebrovascular and neurosurgical fields.
Yu Hyun-seung, Chief Executive Officer (CEO) of CGBIO, emphasized that cerebrovascular bypass surgeries demand exceptional skill, making repetitive hands-on training in near-surgical conditions essential. It aims to develop RISE into a premier training platform for cerebrovascular and neurosurgical techniques, ultimately enhancing the clinical capabilities of medical professionals.
CGBIO is a biotechnology company specializing in the development and production of human tissue-based medical devices and regenerative medical materials. Their focus lies in tissue engineering products, including acellular dermal matrix (ADM) and bone graft materials.
The U.S. market for bone graft substitutes in spinal fusion procedures is a high-value sector dominated by global medical device giants like Medtronic. Industry experts consider the U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) approval a critical factor in determining global market entry potential and product competitiveness.